3D Printing for Medical Sector Market To Witness Robust Expansion Throughout The Forecast Period 2018 - 2026 By Major Players 3T RPD, Ltd., EnvisionTEC, Inc., Arcam AB, 3D Systems, Inc., Eos GmbH Electro Optical Systems, Renishaw plc, Stratasys Inc

3D printing is revolutionizing the healthcare industry by providing improved therapy outcomes and affordable medical devices. This technology is enabling manufacturers to produce small and delicate parts of an organ or medical device with a high accuracy, which is a very cumbersome task using current manufacturing capabilities. Companies such as EnvisionTEC, Inc., 3D Systems, Inc., Stratasys Inc., Materialise NV, and Organovo Holdings, Inc. are collaborating with each other or independent research organizations and institutes to speed-up the research activities in order to decrease the time to market (TTM).

Ask For Sample Copy of This Business report @ https://www.coherentmarketinsights.com/insight/request-sample/80

Market Dynamics

3D printing offers various benefits such as pre-operative planning of medical procedures based on the 3D model, creating anatomical models for training, creating medical products at lower costs, and possibility of manufacturing medical devices of smaller form factors with higher precision. Increasing awareness about cost benefits offered by this technology has increased its usage in hospitals, dentists, pharmaceutical companies, academic institutions, and medical clinics is propelling the market growth for 3D printing. Furthermore, growing demand for organ transplantation and funding from government and private Institution are analyzed be the major factors propelling growth of 3D printing application in the medical sector.

3D printing is a rapidly emerging cost-effective technology with significant potential to transform healthcare delivery and clinical activities. This technology can be used in a range of devices such as prostheses, hearing aids, custom-made knee and hip implants, dental implants, and surgical instruments. The global 3D printing for medical sector market was valued at US$ 412.2 million in 2015 and is expected to expand at a CAGR of 11.7% during the forecast period (2016 – 2024).

Reasonable price of 3D printed medical products leading to increasing popularity

Regional governments of various countries are focusing on burden of expensive medicines on patients through effective price control measures. However, reducing profit margins negatively impact investments in research and development (R&D) phase. 3D printed medical products can effectively address the concerns of governments and the industry. Spritam (Levetiracetam) from Aprecia Pharmaceuticals, is the first 3D printed tablet that received U.S. FDA approval in March 2016. Low cost of production would in turn reduce cost of product and make it more affordable to patients. Researchers are the University of Toronto, Autodesk Research, and CBM Canada used 3D printing to produce low cost customizable prosthetic sockets for patients especially in low-income countries especially Uganda. This would further boost investment in 3D printing by healthcare providers to reduce product cost and increase profit margins.

Different raw materials cater to different 3D printing demands

3D printing technology uses numerous materials such as the metals, ceramics, polymers, and biological cells for printing skin, organs, and medical devices. Metal printing is widely used in prosthetics and implants. Biological cells are widely used in skin and tissue printing. In 2014, L’Oreal S.A. announced partnership with Organovo Holdings, Inc. to 3D-print human skin. Organovo printed the first blood vessel in 2009 and is in the process of developing 3D-printed tissues through strategic partnerships with biopharmaceutical companies. The Wake Forest Institute for Regenerative Medicine (WFIRM)—a research institute associated with Wake Forest School of Medicine—is involved in printing organs and tissue using gel and patient’s own cells. Ceramic is used in dental implants printing. Also, prosthetics can be printed using ceramics and polymers. Polymers are used in printing dental, orthopedic and cranio-maxillofacial implants, and biological models.

Request Customization @ https://www.coherentmarketinsights.com/insight/request-customization/80

Favorable government policies and government funding to boost the 3D printing market for medical applications

The U.S. government is encouraging innovation in healthcare through funding and establishing manufacturing hubs. For instance, in 2014, the National Institutes of Health established a 3D Print Exchange organization to promote open-source sharing of biomedical 3D print files and tutorials. While the U.S. FDA currently approves only dental, orthopedics, cranio-maxillary and tissue engineering for 3D printing, clearance of the 3D printing in other segments would boost the 3D printing market growth significantly. Similarly, the Japanese government supports manufacture and sales of professional-grade printers for 3D printing (also used for medical applications).

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.